U.S. federal trademark · Serial No. 50141295
Scientific research and development; Scientific research for medical purposes in the field of central nervous system disorders, metabolic disorders, or cancer; Research and development in the field of pharmaceuticals and medical treatment; Scientific research in the field of pharmaceuticals and medical treatment; Providing medical and scientific research information; Medical research; Providing information about medical and scientific research; Medical research in the field of central nervous system disorders, metabolic disorders, and cancer; Research and development in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Laboratory research in the field of pharmaceuticals; Research and development of new products in the field of pharmaceuticals; Research and development in the field of pharmaceuticals; Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical research and development; Pharmaceutical products development; Pharmaceutical research in the field of central nervous system disorders, metabolic disorders, and cancer; Research and development in the field of small molecule kinase inhibitors; Research and development in the field of treatments for central nervous system disorders; Research and development in the field of treatments for metabolic disorders; Research and development in the field of treatments for cancer; Research and development services in the field of pharmaceutical preparations; Research and development of medicines; Medical and scientific research in the field of central nervous system disorders, metabolic disorders, and cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.